AKT2
Top View
- Discovery of Potent and Selective MRCK Inhibitors with Therapeutic
- Mutations and Deregulation of Ras/Raf/MEK/ERK and PI3K/ PTEN/Akt/Mtor Cascades Which Alter Therapy Response
- Dual-Targeting AKT2 and ERK in Cancer Stem-Like Cells in Neuroblastoma
- RNA-Seq Identifies Condition-Specific Biological Signatures of Ischemia
- Hereditary Cancer Panel Descriptions
- AKT As a Therapeutic Target for Cancer Mengqiu Song1,2, Ann M
- BRAF Cooperates with PI3K Signaling, Independent of AKT, to Regulate
- Selective Targeting of Cyclin E1-Amplified High-Grade Serous Ovarian Cancer by Cyclin-Dependent Kinase 2 and AKT Inhibition
- Nexus Between PI3K/AKT and Estrogen Receptor Signaling in Breast Cancer
- AKT1 and AKT2 Mutations in Lung Cancer in a Japanese Population
- Involvement of PI3K/Akt Pathway in Cell Cycle Progression
- Activating AKT2 Mutation: Hypoinsulinemic Hypoketotic Hypoglycemia
- A Resource for Exploring the Understudied Human Kinome for Research and Therapeutic
- Regulation of Mtorc2 Signaling
- Upstream and Downstream of Mtor
- PKBΑ Isoform Signaling
- Depletion of Akt1 and Akt2 Impairs the Repair of Radiation-Induced DNA Double Strand Breaks Via Homologous Recombination
- Targeting CDK9 for Anti-Cancer Therapeutics